CMA COMERICA INC Insider Trading

EVP Fleming sold 8,864 shares of CMA at $94.47; now holds 19,565 shares post-transaction.

Fleming Allysun C, Executive Vice President of Comerica Inc, executed a single sale of 8,864 shares at $94.47 on 2026-01-27 for a total value of $837,382.08, reducing her holdings by -31.2% from 28,429 shares to 19,565 shares. The transaction occurred near the stock's 52-week high of $98.59 and reflects a material reduction in her ownership stake. The company operates with a P/E of 16.55 and posted -3.3% annual revenue growth in the most recent fiscal period, creating a mixed fundamental backdrop. Without context regarding scheduled trading plans or prior transaction patterns, this sale represents a significant reduction in executive-level ownership at a prominent regional financial institution.

EVP James Weber sold 8,798 shares of CMA at $98.04; held 29,341 shares pre-sale, 20,543 post.

Executive Vice President James Weber sold 8,798 shares at $98.04 on 2026-01-22, reducing his holdings by 30.0% from 29,341 to 20,543 shares. The transaction occurred near the 52-week high of $98.59, with the stock currently trading at $94.66 and having appreciated 7.0% over 30 days and 21.0% over 90 days. This substantial reduction in an EVP's stake—generating $862,555.92 in proceeds—warrants attention given the executive's senior position and the significant portion of holdings disposed. Without access to scheduled trading plan details or insider track record data, the timing relative to the recent price strength cannot be independently characterized as deliberate positioning versus routine rebalancing.

Sr EVP & Chief Banking Officer Sefzik sells 19,941 shares (~30% of holdings) for $1.09M at $54.63 avg

On 2025-05-01, Peter L Sefzik, Sr EVP & Chief Banking Officer at Comerica Inc, executed 2 separate sales totaling 19,941 shares for $1,089,471.38 at a blended average price of $54.63. This sale reduced his holdings from 67,266 shares to 47,325 shares, a decline of 29.6% versus pre-transaction holdings. The current price of $55.79 stands -23.3% below the 52-week high of $72.73, and the stock has declined 17.7% over the past 90 days despite a +8.1% move in the last 30 days. No prior track record or scheduled plan information is available in the filing data, so the decision context cannot be determined from the facts provided.